Articles and Insights About Wearables for Clinical Trials

Company News

VivoSense Marks Rare Disease Day

 Dudley Tabakin

VivoSense recognizes Rare Disease Day by minding the importance of discovering new advancements in research and clinical trials to care for those with rare diseases. There are approximately 30 million Americans living with rare diseases today, and research into new therapies is imperative for these patients.

Read More

Colin Bower Joins VivoSense as Chief Executive Officer

 Dudley Tabakin

We are thrilled to announce Colin Bower as our new Chief Executive Officer and a member of our Board of Directors. Bower will succeed Dudley Tabakin, who will work closely with Bower to achieve a seamless transition. Tabakin will continue with VivoSense in his new capacity as Chief Product Officer.

Read More

Reverse Engineering Digital Measures: A Patient-Centric Approach

 Ieuan Clay, PhD

In September 2022, a broad range of stakeholders representing regulators, Pharma and Biotech firms, technology service providers, innovators, and patients gathered in Zürich. This meeting, the second in a series hosted by the Swiss Federal Institute of Technology and the Foundation for the National Institutes of Health Biomarkers Consortium, sought to explore the role patient centricity must play in the development and validation of digital tools for gathering evidence. Director of Science Ieuan Clay, a member of the Biomarkers Consortium, represented VivoSense in the discussion examining four case studies of interest:

Read More

VivoSense Collaborates with Cambridge Cognition on the MEADOW-AD Study

 Kate Lyden, PhD

VivoSense is excited to announce a collaboration with Cambridge Cognition to capture measures of cognitive and physical function using digital health tools. Both organizations are united in their interests to develop low-burden and patient-centric digital clinical outcome measures that more comprehensively and holistically capture how individuals function in real-world environments.

Read More

VivoSense Joins CancerX to Advance Digital Innovation in Research

 Ieuan Clay, PhD

On June 2, 2023, at ASCO, CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), announced its founding members. VivoSense is proud to be among other organizations striving to eradicate cancer!

Read More

VivoSense Joins the FNIH Biomarkers Consortium

 Dudley Tabakin

VivoSense announces that we have joined the Foundation for the National Institutes of Health’s (FNIH) Biomarkers Consortium! This new partnership strengthens our joint mission to facilitate the development of novel digital biomarkers using new and existing technologies, including evidence for their qualification in diagnostic medicine, therapeutic development, and clinical practice improvement.

Read More

VivoSense Joins Clinical Trials Transformation Initiative (CTTI)

 Dudley Tabakin

VivoSense, Inc. has joined the Clinical Trials Transformation Initiative (CTTI) to advance the efficiency and efficacy of clinical trial research and care. As a leading provider of digital endpoint solutions derived from wearable sensors, VivoSense will contribute to CTTI's foundational efforts to improve quality, patient engagement, novel trial design, digital health trials, investigator, and site support and ethics in research.

Read More

VivoSense Announces Expanded Collaboration with RSRT

 Dudley Tabakin

VivoSense announces an expansion of our collaboration with the Rett Syndrome Research Trust (RSRT). Building on the success of our previous collaborations, VivoSense and RSRT will continue to support the development of treatments for Rett Syndrome (RTT) by qualifying objective digital outcome measures of breathing problems for use in RTT trials.

Read More

VivoSense Joins DiMe's Core Measures of Sleep Project

 Kate Lyden, PhD

We are excited to announce our participation in the Digital Medicine Society's (DiMe) latest digital clinical measures project, Core Measures of Sleep. In partnership with the Digital Medicine Society and other leaders in the field, we are paving the way for better approaches to collecting, analyzing, and interpreting sleep data.

Read More

VivoSense Awarded NIA/MassAITC Grant to Aid in Alzheimer's Research

 Dudley Tabakin

VivoSense, a trusted leader in the development, validation, and delivery of digital clinical measures, announced today that it has been awarded a research grant funded by the National Institute of Aging (NIA) and the Massachusetts Artificial Intelligence and Technology Center for Connected Care in Aging & Alzheimer’s Disease (MassAITC; grant number 5P30AG073107-02 Pilot A2).

Read More

Stay Connected

Popular